Galderma Group Ltd header image

Galderma Group Ltd

GALD

Equity

ISIN CH1335392721 / Valor 133539272

SIX Swiss Exchange (2026-07-08)

CHF 176.35-1.01%

Galderma Group Ltd
UMushroom community rating:

4.33 3 votes No rating yet

NegativeNeutralPositive

About company

Galderma Group Ltd is a leading company in the dermatology sector, focusing exclusively on this field for over 40 years. The company specializes in developing, manufacturing, and marketing a wide range of dermatological treatments and solutions. Galderma's product portfolio includes therapeutic dermatology products, dermatological skincare, and injectable aesthetic treatments, catering to a diverse range of skin health needs. With a global presence, the company operates research and development centers and manufacturing facilities strategically located around the world. Galderma is dedicated to advancing the field of dermatology through continuous innovation and science-based solutions, aiming to enhance the quality of life for patients with various skin conditions.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

45.5%1Y

%3Y

%5Y

Performance

28.7%1Y

31.0%3Y

31.0%5Y

Volatility

51268 M

Market cap (USD)

441,494

Daily traded volume (Shares)

100.6 / 98.35

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.33

3 votes

Performance:

4.00

Innovation:

4.00

Society:

3.00

Nature:

2.67

Laura Bischofberger

Switzerland, 12 Jun 2024

New kid on the block, lets see where they go after they IPO.

Hein Sweerts de Landas

Switzerland, 12 Jun 2024

It's the trend, personal beautification. Online: photoshop, real world: Galderma!

Admin UMushroom

Switzerland, 12 Jun 2024

Was never too keen on this type of procedures.

EQUITIES OF THE SAME SECTOR

Asker Healthcare Group AB

Asker Healthcare Group AB Valor: 143378021

Annual Return

-50%0%+50%

Risk level

110

0.67%SEK 83.20

Alkem Laboratories Ltd.

Alkem Laboratories Ltd. Valor: 30689895

Annual Return

-50%0%+50%

Risk level

110

1.20%INR 5,664.75

Swedish Orphan Biovitrum AB

Swedish Orphan Biovitrum AB Valor: 2676862

Annual Return

-50%0%+50%

Risk level

110

-0.04%SEK 479.80

Indivior PLC

Indivior PLC Valor: 121550831

Annual Return

-50%0%+50%

Risk level

110

1.93%GBP 30.52

Spire Healthcare Group PLC

Spire Healthcare Group PLC Valor: 24881418

Annual Return

-50%0%+50%

Risk level

110

0.23%GBP 2.17

Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA Valor: 332902

Annual Return

-50%0%+50%

Risk level

110

0.49%EUR 43.41

L'Oreal S.A.

L'Oreal S.A. Valor: 502805

Annual Return

-50%0%+50%

Risk level

110

2.74%EUR 388.35

MPH Health Care AG

MPH Health Care AG Valor: 57233620

Annual Return

-50%0%+50%

Risk level

110

0.34%EUR 29.30

The Platform Group AG

The Platform Group AG Valor: 57796644

Annual Return

-50%0%+50%

Risk level

110

-0.67%EUR 0.89

Geratherm Medical AG

Geratherm Medical AG Valor: 1091371

Annual Return

-50%0%+50%

Risk level

110

2.22%EUR 2.76

SIX

FactSet

Clearbit

Logos provided by Clearbit